|
LY 2119620,M2和M4受体的正变构调节剂
|
L288532-50mg
|
Moligand™, ≥98%(HPLC) |
886047-22-9 |
50mg
|
¥ 5809.9
|
现货 |
|
0 |
阿拉丁 |
|
LY 2119620,M2和M4受体的正变构调节剂
|
L288532-10mg
|
Moligand™, ≥98%(HPLC) |
886047-22-9 |
10mg
|
¥ 1566.9
|
现货 |
|
0 |
阿拉丁 |
|
(±)-LY 395756,mGlu2和mGlu3受体的配体
|
L288487-50mg
|
Moligand™, ≥98%(HPLC) |
852679-66-4 |
50mg
|
¥ 9682.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(±)-LY 395756,mGlu2和mGlu3受体的配体
|
L288487-10mg
|
Moligand™, ≥98%(HPLC) |
852679-66-4 |
10mg
|
¥ 2349.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L-755,507,β3部分激动剂
|
L288431-50mg
|
Moligand™, ≥98%(HPLC) |
159182-43-1 |
50mg
|
¥ 3328.9
|
现货 |
|
0 |
阿拉丁 |
|
L-755,507,β3部分激动剂
|
L288431-10mg
|
Moligand™, ≥98%(HPLC) |
159182-43-1 |
10mg
|
¥ 833.9
|
现货 |
|
0 |
阿拉丁 |
|
L-651,582,Ca2 +通道阻滞剂
|
L288429-50mg
|
≥98%(HPLC) |
99519-84-3 |
50mg
|
¥ 5669.9
|
现货 |
|
0 |
阿拉丁 |
|
L-651,582,Ca2 +通道阻滞剂
|
L288429-10mg
|
≥98%(HPLC) |
99519-84-3 |
10mg
|
¥ 1399.9
|
现货 |
|
0 |
阿拉丁 |
|
L-693,403 马来酸盐
|
L288428-50mg
|
≥98% |
207455-21-8 |
50mg
|
¥ 4872.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
L-693,403 马来酸盐
|
L288428-10mg
|
≥98% |
207455-21-8 |
10mg
|
¥ 1164.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LG 101506,RXR调制器
|
L288411-50mg
|
≥98%(HPLC) |
331248-11-4 |
50mg
|
¥ 9785.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LG 101506,RXR调制器
|
L288411-10mg
|
≥98%(HPLC) |
331248-11-4 |
10mg
|
¥ 2462.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LIMKi 3,LIM激酶抑制剂
|
L288407-10mg
|
Moligand™, ≥98%(HPLC) |
1338247-35-0 |
10mg
|
¥ 741.9
|
现货 |
|
0 |
阿拉丁 |
|
LTURM 36,PI 3-激酶δ抑制剂
|
L288389-50mg
|
≥98%(HPLC) |
1879887-94-1 |
50mg
|
¥ 6232.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LTURM 36,PI 3-激酶δ抑制剂
|
L288389-10mg
|
≥98%(HPLC) |
1879887-94-1 |
10mg
|
¥ 1484.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LOC14,蛋白质二硫键异构酶(PDI)调节剂
|
L288383-50mg
|
≥98%(HPLC) |
877963-94-5 |
50mg
|
¥ 4119.9
|
现货 |
|
0 |
阿拉丁 |
|
LOC14,蛋白质二硫键异构酶(PDI)调节剂
|
L288383-10mg
|
≥98%(HPLC) |
877963-94-5 |
10mg
|
¥ 1251.9
|
现货 |
|
0 |
阿拉丁 |
|
LY 334370 盐酸盐
|
L288339-50mg
|
≥99%(HPLC) |
199673-74-0 |
50mg
|
¥ 7344.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LY 334370 盐酸盐
|
L288339-10mg
|
≥99%(HPLC) |
199673-74-0 |
10mg
|
¥ 1999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LM 10,色氨酸2,3-二加氧酶(TDO)抑制剂
|
L288335-50mg
|
Moligand™, ≥98%(HPLC) |
1316695-35-8 |
50mg
|
¥ 1287.9
|
现货 |
|
0 |
阿拉丁 |
|
LM 10,色氨酸2,3-二加氧酶(TDO)抑制剂
|
L288335-10mg
|
Moligand™, ≥98%(HPLC) |
1316695-35-8 |
10mg
|
¥ 331.9
|
现货 |
|
0 |
阿拉丁 |
|
L-R4W2,TRPV1拮抗剂肽
|
L288302-1mg
|
≥98% |
206350-79-0 |
1mg
|
¥ 102.9
|
现货 |
|
0 |
阿拉丁 |
|
LUF 5834,腺苷A2A和A2B受体部分激动剂
|
L288299-50mg
|
≥98%(HPLC) |
333962-91-7 |
50mg
|
¥ 9899.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
LUF 5834,腺苷A2A和A2B受体部分激动剂
|
L288299-10mg
|
≥98%(HPLC) |
333962-91-7 |
10mg
|
¥ 2359.9
|
期货,请咨询 |
|
0 |
阿拉丁 |